市场调查报告书
商品编码
1291356
心血管设备市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Cardiovascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球心血管设备市场规模达到554亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到827亿美元,在2023-2028年期间呈现6.4%的增长率(CAGR)。
心血管设备是指用于诊断和治疗心脏疾病和相关健康问题的各种医疗仪器。它们被设计用来帮助疾病监测和手术干预。一些常用的心血管设备包括支架、心脏瓣膜、移植物、导管、心电图(ECG)、远程心脏监测和心脏辅助设备。心血管设备在整个医疗保健领域有广泛的应用,因为它们有助于有效管理威胁生命的疾病,最大限度地减少病人的不适,并提高生活质量。如今,制造商正专注于开发先进的植入式心血管设备,这使其在全球的需求不断增加。
由于久坐的生活方式和不健康的饮食模式和习惯,如吸烟和饮酒,导致心血管疾病(CVDs)的广泛流行,这是推动市场增长的主要因素。除此之外,老年人口的增长是另一个主要的增长诱因,因为他们更容易受到慢性心脏疾病的影响。此外,采用家庭保健设备的情况也有明显增加。与此同时,对能够让病人移动并同时提供实时数据的紧凑型心血管设备的需求不断增加,这也增强了产品的需求。此外,领先的企业正专注于研究和开发(R&D)活动,推出集成了先进技术和功能的创新产品,从而促进了市场的增长。此外,大众对现有心血管设备的认识不断提高,以及对微创(MI)手术的偏好转变,正在加速产品的采用率。其他因素,包括无线心电图的推出,对连续和基于家庭的监测需求的增长,以及技术进步,也正在创造一个积极的市场前景。
The global cardiovascular devices market size reached US$ 55.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.
Cardiovascular devices refer to various medical instruments that are employed for diagnosing and treating heart diseases and related health problems. They are designed to aid in disease monitoring and surgical interventions. Some commonly used cardiovascular devices include stents, heart valves, grafts, catheters, electrocardiogram (ECG), remote cardiac monitoring, and cardiac assist devices. Cardiovascular devices find extensive applications across the healthcare sector as they assist in managing life-threatening conditions effectively, minimizing patient discomfort, and enhancing the quality of life. Nowadays, manufacturers are focusing on developing advanced implantable cardiovascular devices, which is escalating their demand across the globe.
The widespread prevalence of cardiovascular diseases (CVDs) on account of sedentary lifestyles, and unhealthy dietary patterns and habits, such as smoking and alcohol consumption, represents the primary factor driving the market growth. Besides this, the growing geriatric population is another major growth-inducing factor as they are more susceptible to chronic heart ailments. Additionally, there has been a significant increase in the adoption of home healthcare devices. Along with this, the rising need for compact cardiovascular devices that enable patient mobility and simultaneously provide real-time data is augmenting the product demand. Furthermore, the leading players are focusing on research and development (R&D) activities to launch innovative product variants integrated with advanced technologies and features, thereby contributing to the market growth. Moreover, the rising awareness regarding the available cardiovascular devices among the masses and the shifting preferences toward minimally invasive (MI) procedures are accelerating the product adoption rates. Other factors, including the launch of wireless ECG, growing demand for continuous and home-based monitoring, and technological advancements, are also creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiovascular devices market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device type, application and end user.
Diagnostic and Monitoring Devices
Electrocardiogram (ECG)
Remote Cardiac Monitoring
Others
Therapeutic and Surgical Devices
Cardiac Rhythm Management (CRM) Devices
Catheter
Stents
Heart Valves
Others
Coronary Artery Disease (CAD)
Cardiac Arrhythmia
Heart Failure
Others
Hospitals
Specialty Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG) and Terumo Cardiovascular Systems Corporation (Terumo Corporation).
Key Questions Answered in This Report
1. What was the size of the global cardiovascular devices market in 2022?
2. What is the expected growth rate of the global cardiovascular devices market during 2023-2028?
3. What has been the impact of COVID-19 on the global cardiovascular devices market?
4. What are the key factors driving the global cardiovascular devices market?
5. What is the breakup of the global cardiovascular devices market based on the device type?
6. What is the breakup of the global cardiovascular devices market based on the application?
7. What is the breakup of the global cardiovascular devices market based on the end user?
8. What are the key regions in the global cardiovascular devices market?
9. Who are the key players/companies in the global cardiovascular devices market?